First-pass effect after rectal administration of thiazinamium methylsulfate

Area of Science:

• Pharmacokinetics
• Drug Metabolism
• Human Physiology

Background:

• Quaternary ammonium compounds are used in various pharmaceutical applications.
• Understanding drug absorption and metabolism is crucial for effective drug delivery.
• Thiazinamium methylsulfate is a quaternary ammonium compound requiring pharmacokinetic evaluation.

Purpose of the Study:

• To investigate the absorption and metabolism of thiazinamium methylsulfate in humans.
• To compare the relative bioavailability and first-pass effect of rectal versus oral administration.
• To assess the pharmacokinetic profile of thiazinamium methylsulfate via rectal delivery.

Main Methods:

• Human studies involving plasma concentration data analysis.
• Urinary excretion measurements to track drug elimination.
• Administration of thiazinamium methylsulfate via suppositories (150 mg dose).

Main Results:

• Rectal administration of thiazinamium methylsulfate yielded a relative bioavailability of 5.8% +/- 3.2% (SD).
• The bioavailability following rectal administration was comparable to oral administration.
• The first-pass effect after rectal administration was similar to that observed after oral administration.

Conclusions:

• Rectal administration of thiazinamium methylsulfate results in limited systemic absorption.
• The drug undergoes significant first-pass metabolism, whether administered rectally or orally.
• Pharmacokinetic data suggest rectal delivery may not offer significant advantages over oral routes for thiazinamium methylsulfate in terms of bioavailability.